Alerts will be sent to your verified email
Verify Email
PCL
|
Prospect Consumer
|
Dipna Pharma.
|
Agarwal Float Glass
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.35 % | 16.1 % | 11.73 % |
|
5yr average Equity Multiplier
|
1.3 | 14.87 | 5.1 |
|
5yr Average Asset Turnover Ratio
|
0.77 | 1.35 | 2.07 |
|
5yr Avg Net Profit Margin
|
3.81 % | 0.81 % | 1.73 % |
|
Price to Book
|
0.0 | 1.25 | 0.0 |
|
P/E
|
23.77 | 49.25 | 15.84 |
|
5yr Avg Cash Conversion Cycle
|
119.16 Days | -33.62 Days | 106.61 Days |
|
Inventory Days
|
35.01 Days | 62.45 Days | 68.91 Days |
|
Days Receivable
|
87.88 Days | 112.8 Days | 54.54 Days |
|
Days Payable
|
16.89 Days | 139.84 Days | 27.02 Days |
|
5yr Average Interest Coverage Ratio
|
3.46 | 2.01 | 2.05 |
|
5yr Avg ROCE
|
4.07 % | 12.33 % | 30.51 % |
|
5yr Avg Operating Profit Margin
|
7.96 % | 2.41 % | 4.98 % |
|
5 yr average Debt to Equity
|
0.13 | 5.84 | 3.11 |
|
5yr CAGR Net Profit
|
n/a | 117.34 % | 16.12 % |
|
5yr Average Return on Assets
|
-0.14 % | 1.21 % | 3.38 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.92 % | 9.98 % | 57.55 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-11.02 % | -56.58 % | -12.22 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Prospect Consumer
|
Dipna Pharma.
|
Agarwal Float Glass
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|